On May 30th, the US Treasury announced sanctions against 13 Chinese entities and individuals for involvement in the cross-border sale of illegal drug production equipment.

        The spokesperson of the Chinese Embassy in the United States responded on this matter, stating that on the one hand, the United States has expressed its desire for China to resume drug control cooperation, and on the other hand, it has blatantly sanctioned Chinese entities and individuals again, seriously infringing on the legitimate rights and interests of relevant enterprises and individuals. China strongly condemns this.

        The spokesman said that the excuse for the US side to implement the sanctions was that these Chinese entities and individuals sold Tablet press, molds and other equipment to the US and Mexico. As we all know, Tablet press and mould are common commodities, which have legal uses and are widely used in normal industrial production. Moreover, according to international practices and practices, ensuring that international goods are not used for illegal purposes is the basic responsibility of importing enterprises and also a legal obligation of the importing country's government.

        China has always strictly enforced drug control and, in a humanitarian spirit, has been doing its best to help the US address and resolve the fentanyl issue. In May 2019, China took the lead in classifying and controlling fentanyl substances globally, playing an important role in preventing its illegal production, trafficking, and abuse. But the US side not only disregards China's goodwill, but instead insists on unjustifiably sanctioning institutions such as the Physical Evidence Appraisal Center of the Chinese Ministry of Public Security and the National Drug Laboratory on the grounds of so-called human rights issues in Xinjiang. Now, it has repeatedly sanctioned Chinese enterprises and individuals, "throwing blame" at China, seriously damaging the foundation of bilateral drug control cooperation.

        The spokesperson emphasized that the root cause of the proliferation of domestic drugs in the United States lies in the United States itself. The United States, with only 5% of the global population, consumes 80% of the world's opioid substances, and so far there is no permanent whole class fentanyl. In the context of increasingly strict control of fentanyl like substances by the international community and China, the problem of fentanyl in the United States continues to worsen, with the number of fatalities increasing instead of decreasing. The United States should deeply reflect on this. The United States does not start with reducing domestic drug demand, strengthening prescription drug control, and strengthening drug hazard propaganda and education. Instead, it arbitrarily wields sanctions against other countries, attempting to confuse the public, mislead the public, and transfer responsibility for its own inadequate governance. The American people and the international community are well aware of this.

        The sanctions imposed by the United States on Chinese enterprises and citizens will create further obstacles to China US drug cooperation, causing harm to others and oneself. If the US sincerely wants to solve the domestic drug problem, it should respect the facts, reflect on itself, correct mistakes, and stop blaming others. China will continue to take necessary measures to safeguard the legitimate rights and interests of Chinese enterprises and individuals.

*Disclaimer: The above content is reproduced on the WeChat official account of the semiconductor industry circle, which does not represent the views and positions of the company, but only for exchange and learning. If you have any questions or objections, please contact us.